-
1
-
-
0025141337
-
What is the evidence that tumors are angiogenesis dependent?
-
J. Folkman 1990 What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82 1 4 6 1688381 10.1093/jnci/82.1.4 1:STN:280:DyaK3c%2FnvF2qug%3D%3D (Pubitemid 20020880)
-
(1990)
Journal of the National Cancer Institute
, vol.82
, Issue.1
, pp. 4-6
-
-
Folkman, J.1
-
2
-
-
0027197245
-
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
-
DOI 10.1038/362841a0
-
K.J. Kim B. Li J. Winer, et al. 1993 Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo Nature 362 6423 841 844 7683111 10.1038/362841a0 1:CAS:528:DyaK3sXktVKju7s%3D (Pubitemid 23132159)
-
(1993)
Nature
, vol.362
, Issue.6423
, pp. 841-844
-
-
Kim, K.J.1
Li, B.2
Winer, J.3
Armanini, M.4
Gillett, N.5
Phillips, H.S.6
Ferrara, N.7
-
3
-
-
0034693631
-
Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non small cell lung cancer
-
11102890 10.1002/1097-0215(20001120)89:6<475::AID-IJC2>3.0.CO;2-T 1:CAS:528:DC%2BD3cXptVejsrs%3D
-
A. Yuan C.J. Yu W.J. Chen, et al. 2000 Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non small cell lung cancer Int J Cancer 89 6 475 483 11102890 10.1002/1097-0215(20001120)89:6<475::AID-IJC2>3.0.CO;2-T 1:CAS:528:DC%2BD3cXptVejsrs%3D
-
(2000)
Int J Cancer
, vol.89
, Issue.6
, pp. 475-483
-
-
Yuan, A.1
Yu, C.J.2
Chen, W.J.3
-
4
-
-
56349136033
-
Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors
-
18843117 10.1242/jcs.016410 1:CAS:528:DC%2BD1cXhsVaitLbI
-
D.G. Nowak J. Woolard E.M. Amin, et al. 2008 Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors J Cell Sci 121 20 3487 3495 18843117 10.1242/jcs.016410 1:CAS:528:DC%2BD1cXhsVaitLbI
-
(2008)
J Cell Sci
, vol.121
, Issue.20
, pp. 3487-3495
-
-
Nowak, D.G.1
Woolard, J.2
Amin, E.M.3
-
5
-
-
0037098860
-
165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma
-
165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma Cancer Res 62 14 4123 4131 12124351 1:CAS:528:DC%2BD38XlsV2ltrw%3D (Pubitemid 34791084)
-
(2002)
Cancer Research
, vol.62
, Issue.14
, pp. 4123-4131
-
-
Bates, D.O.1
Cui, T.-G.2
Doughty, J.M.3
Winkler, M.4
Sugiono, M.5
Shields, J.D.6
Peat, D.7
Gillatt, D.8
Harper, S.J.9
-
6
-
-
70349663980
-
VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo
-
19707198 10.1038/sj.bjc.6605249 1:CAS:528:DC%2BD1MXhtF2lu7rE
-
E.S. Rennel A.H. Varey A.J. Churchill, et al. 2009 VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo Br J Cancer 101 7 1183 1193 19707198 10.1038/sj.bjc.6605249 1:CAS:528:DC%2BD1MXhtF2lu7rE
-
(2009)
Br J Cancer
, vol.101
, Issue.7
, pp. 1183-1193
-
-
Rennel, E.S.1
Varey, A.H.2
Churchill, A.J.3
-
7
-
-
33748479489
-
A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2
-
DOI 10.1007/s00018-006-6254-9
-
S. Cebe Suarez M. Pieren L. Cariolato, et al. 2006 A VEGF-A splice variant defective for heparan sulfate and neuropilin- 1 binding shows attenuated signaling through VEGFR-2 Cell Mol Life Sci 63 17 2067 2077 16909199 10.1007/s00018-006-6254-9 1:STN:280:DC%2BD28rjsValsg%3D%3D (Pubitemid 44359746)
-
(2006)
Cellular and Molecular Life Sciences
, vol.63
, Issue.17
, pp. 2067-2077
-
-
Cebe Suarez, S.1
Pieren, M.2
Cariolato, L.3
Arn, S.4
Hoffmann, U.5
Bogucki, A.6
Manlius, C.7
Wood, J.8
Ballmer-Hofer, K.9
-
8
-
-
7444240909
-
165b, an inhibitory vascular endothelial growth factor splice variant: Mechanism of action, in vivo effect on angiogenesis and endogenous protein expression
-
DOI 10.1158/0008-5472.CAN-04-0934
-
165b, an inhibitory vascular endothelial growth factor splice variant Cancer Res 64 21 7822 7835 15520188 10.1158/0008-5472.CAN-04-0934 1:CAS:528:DC%2BD2cXptFemu7k%3D (Pubitemid 39446915)
-
(2004)
Cancer Research
, vol.64
, Issue.21
, pp. 7822-7835
-
-
Woolard, J.1
Wang, W.-Y.2
BeVan, H.S.3
Qiu, Y.4
Morbidelli, L.5
Pritchard-Jones, R.O.6
Cui, T.-G.7
Sugiono, M.8
Waine, E.9
Perrin, R.10
Foster, R.11
Digby-Bell, J.12
Shields, J.D.13
Whittles, C.E.14
Mushens, R.E.15
Gillatt, D.A.16
Ziche, M.17
Harper, S.J.18
Bates, D.O.19
-
9
-
-
60549093223
-
165b in maternal plasma is a first trimester predictive marker for pre-eclampsia
-
10.1042/CS20080270 1:CAS:528:DC%2BD1MXis1OisA%3D%3D
-
165b in maternal plasma is a first trimester predictive marker for pre-eclampsia Clin Sci (Lond) 116 3 265 272 10.1042/CS20080270 1:CAS:528:DC%2BD1MXis1OisA%3D%3D
-
(2009)
Clin Sci (Lond)
, vol.116
, Issue.3
, pp. 265-272
-
-
Bills, V.L.1
Varet, J.2
Millar, A.3
-
10
-
-
33646711885
-
xxxb, are down-regulated in pre-eclamptic placentae at term
-
DOI 10.1042/CS20050292
-
D.O. Bates P.P. MacMillan J.G. Manjaly, et al. 2006 The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclam ptic placentae at term Clin Sci (Lond) 110 5 575 585 10.1042/CS20050292 1:CAS:528:DC%2BD28XjtlCgsL4%3D (Pubitemid 43736120)
-
(2006)
Clinical Science
, vol.110
, Issue.5
, pp. 575-585
-
-
Bates, D.O.1
MacMillan, P.P.2
Manjaly, J.G.3
Qiu, Y.4
Hudson, S.J.5
BeVan, H.S.6
Hunter, A.J.7
Soothill, P.W.8
Read, M.9
Donaldson, L.F.10
Harper, S.J.11
-
11
-
-
42149152015
-
165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: Balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
-
DOI 10.1038/sj.bjc.6604308, PII 6604308
-
165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy Br J Cancer 98 8 1366 1379 18349829 10.1038/sj.bjc.6604308 1:CAS:528:DC%2BD1cXks12gurs%3D (Pubitemid 351543576)
-
(2008)
British Journal of Cancer
, vol.98
, Issue.8
, pp. 1366-1379
-
-
Varey, A.H.R.1
Rennel, E.S.2
Qiu, Y.3
BeVan, H.S.4
Perrin, R.M.5
Raffy, S.6
Dixon, A.R.7
Paraskeva, C.8
Zaccheo, O.9
Hassan, A.B.10
Harper, S.J.11
Bates, D.O.12
-
12
-
-
34447316207
-
xxxb, the inhibitory isoforms of VEGF, in malignant melanoma
-
DOI 10.1038/sj.bjc.6603839, PII 6603839
-
R. Pritchard-Jones D. Dunn Y. Qiu, et al. 2007 Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanoma Br J Cancer 97 2 223 230 17595666 10.1038/sj.bjc.6603839 1:CAS:528:DC%2BD2sXnsFaqsLk%3D (Pubitemid 47057469)
-
(2007)
British Journal of Cancer
, vol.97
, Issue.2
, pp. 223-230
-
-
Pritchard-Jones, R.O.1
Dunn, D.B.A.2
Qiu, Y.3
Varey, A.H.R.4
Orlando, A.5
Rigby, H.6
Harper, S.J.7
Bates, D.O.8
-
13
-
-
77949318969
-
Regulation of vascular endothelial growth factor (VEGF) splicing from pro- angiogenic to anti-angiogenic isoforms: A novel therapeutic strategy for angiogenesis
-
19906640 10.1074/jbc.M109.074930 1:CAS:528:DC%2BC3cXhvFCrtbw%3D
-
D.G. Nowak E.M. Amin E.S. Rennel, et al. 2010 Regulation of vascular endothelial growth factor (VEGF) splicing from pro- angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis J Biol Chem 285 8 5532 5540 19906640 10.1074/jbc.M109.074930 1:CAS:528: DC%2BC3cXhvFCrtbw%3D
-
(2010)
J Biol Chem
, vol.285
, Issue.8
, pp. 5532-5540
-
-
Nowak, D.G.1
Amin, E.M.2
Rennel, E.S.3
-
14
-
-
41649101428
-
165b inhibits human tumour growth in mice
-
DOI 10.1038/sj.bjc.6604309, PII 6604309
-
165Best wishes, inhibits human tumour growth in mice Br J Cancer 98 7 1250 1257 18349828 10.1038/sj.bjc.6604309 1:CAS:528:DC%2BD1cXktVKhsLk%3D (Pubitemid 351481687)
-
(2008)
British Journal of Cancer
, vol.98
, Issue.7
, pp. 1250-1257
-
-
Rennel, E.S.1
Waine, E.2
Guan, H.3
Schuler, Y.4
Leenders, W.5
Woolard, J.6
Sugiono, M.7
Gillatt, D.8
Kleinerman, E.S.9
Bates, D.O.10
Harper, S.J.11
-
15
-
-
0037098860
-
165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma
-
165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma Cancer Res 62 14 4123 4131 12124351 1:CAS:528:DC%2BD38XlsV2ltrw%3D (Pubitemid 34791084)
-
(2002)
Cancer Research
, vol.62
, Issue.14
, pp. 4123-4131
-
-
Bates, D.O.1
Cui, T.-G.2
Doughty, J.M.3
Winkler, M.4
Sugiono, M.5
Shields, J.D.6
Peat, D.7
Gillatt, D.8
Harper, S.J.9
-
16
-
-
42049083543
-
165b
-
DOI 10.1096/fj.07-9718com
-
165b Faseb J 22 4 1104 1112 18032632 10.1096/fj.07-9718com 1:CAS:528:DC%2BD1cXktlWnsbk%3D (Pubitemid 351519965)
-
(2008)
FASEB Journal
, vol.22
, Issue.4
, pp. 1104-1112
-
-
Qiu, Y.1
BeVan, H.2
Weeraperuma, S.3
Wratting, D.4
Murphy, D.5
Neal, C.R.6
Bates, D.O.7
Harper, S.J.8
-
17
-
-
77955866848
-
165b is cytoprotective and anti-angiogenic in the retina
-
20237249 10.1167/iovs.09-4296
-
165b is cytoprotective and anti-angiogenic in the retina Invest Ophthalmol Vis Sci 51 8 4273 4281 20237249 10.1167/iovs.09-4296
-
(2010)
Invest Ophthalmol Vis Sci
, vol.51
, Issue.8
, pp. 4273-4281
-
-
Magnussen, A.L.1
Rennel, E.S.2
Hua, J.3
-
18
-
-
77955860259
-
165b inhibits experimental choroidal neovascular isation
-
20237252 10.1167/iovs.09-4360
-
165b inhibits experimental choroidal neovascular isation Invest Ophthalmol Vis Sci 51 8 4282 4288 20237252 10.1167/iovs.09-4360
-
(2010)
Invest Ophthalmol Vis Sci
, vol.51
, Issue.8
, pp. 4282-4288
-
-
Hua, J.1
Spee, C.2
Kase, S.3
-
19
-
-
56749179738
-
The alternatively spliced anti-angiogenic family of VEGF isoforms VEGFxxxb in human kidney development
-
10.1159/000177614
-
H.S. BeVan N.M. Van Den Akker Y. Qiu, et al. 2008 The alternatively spliced anti-angiogenic family of VEGF isoforms VEGFxxxb in human kidney development Nephron Physiol 110 4 57 67 10.1159/000177614
-
(2008)
Nephron Physiol
, vol.110
, Issue.4
, pp. 57-67
-
-
BeVan, H.S.1
Van Den Akker, N.M.2
Qiu, Y.3
-
20
-
-
33646871534
-
165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice
-
165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice Mol Vis 12 626 632 16735996 1:CAS:528:DC%2BD28XntVelsrY%3D (Pubitemid 43786776)
-
(2006)
Molecular Vision
, vol.12
, pp. 626-632
-
-
Konopatskaya, O.1
Churchill, A.J.2
Harper, S.J.3
Bates, D.4
Gardiner, T.A.5
-
21
-
-
49549083692
-
165b protein is an effective anti-cancer agent in mice
-
18657413 10.1016/j.ejca.2008.05.027 1:CAS:528:DC%2BD1cXhtVamt7rF
-
165b protein is an effective anti-cancer agent in mice Eur J Cancer 44 13 1883 1894 18657413 10.1016/j.ejca.2008.05.027 1:CAS:528:DC%2BD1cXhtVamt7rF
-
(2008)
Eur J Cancer
, vol.44
, Issue.13
, pp. 1883-1894
-
-
Rennel, E.S.1
Hamdollah-Zadeh, M.A.2
Wheatley, E.R.3
-
22
-
-
34447316207
-
xxxb, the inhibitory isoforms of VEGF, in malignant melanoma
-
DOI 10.1038/sj.bjc.6603839, PII 6603839
-
R.O. Pritchard-Jones D.B. Dunn Y. Qiu, et al. 2007 Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma Br J Cancer 97 2 223 230 17595666 10.1038/sj.bjc.6603839 1:CAS:528:DC%2BD2sXnsFaqsLk%3D (Pubitemid 47057469)
-
(2007)
British Journal of Cancer
, vol.97
, Issue.2
, pp. 223-230
-
-
Pritchard-Jones, R.O.1
Dunn, D.B.A.2
Qiu, Y.3
Varey, A.H.R.4
Orlando, A.5
Rigby, H.6
Harper, S.J.7
Bates, D.O.8
-
23
-
-
47249094555
-
165b downregulation as a marker of poor prognosis
-
18546269 10.1002/ijc.23619 1:CAS:528:DC%2BD1cXhtVSrsLvF
-
165b downregulation as a marker of poor prognosis Int J Cancer 123 5 1060 1067 18546269 10.1002/ijc.23619 1:CAS:528:DC%2BD1cXhtVSrsLvF
-
(2008)
Int J Cancer
, vol.123
, Issue.5
, pp. 1060-1067
-
-
Diaz, R.1
Pena, C.2
Silva, J.3
-
24
-
-
80051676156
-
Increased VEGFR-2 gene copy is associated with chemoresistance and shorter survival in patients with non-small- cell lung carcinoma who receive adjuvant chemotherapy
-
21724587 10.1158/0008-5472.CAN-10-2614 1:CAS:528:DC%2BC3MXhtVSrtb3F
-
F. Yang X. Tang E. Riquelme, et al. 2011 Increased VEGFR-2 gene copy is associated with chemoresistance and shorter survival in patients with non-small- cell lung carcinoma who receive adjuvant chemotherapy Cancer Res 71 16 5512 5521 21724587 10.1158/0008-5472.CAN-10-2614 1:CAS:528:DC%2BC3MXhtVSrtb3F
-
(2011)
Cancer Res
, vol.71
, Issue.16
, pp. 5512-5521
-
-
Yang, F.1
Tang, X.2
Riquelme, E.3
-
25
-
-
0034891532
-
Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype
-
11485923 10.1016/S0002-9440(10)61736-1 1:CAS:528:DC%2BD3MXms1Wit78%3D
-
S. Soker M. Kaefer M. Johnson, et al. 2001 Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype Am J Pathol 159 2 651 11485923 10.1016/S0002-9440(10)61736-1 1:CAS:528:DC%2BD3MXms1Wit78%3D
-
(2001)
Am J Pathol
, vol.159
, Issue.2
, pp. 651
-
-
Soker, S.1
Kaefer, M.2
Johnson, M.3
-
26
-
-
0033600760
-
Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells
-
DOI 10.1074/jbc.274.39.27617
-
S. Marchiò L. Primo M. Pagano, et al. 1999 Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposis sarcoma cells J Biol Chem 274 39 27 617 27 622 10.1074/jbc.274.39.27617 (Pubitemid 29458009)
-
(1999)
Journal of Biological Chemistry
, vol.274
, Issue.39
, pp. 27617-27622
-
-
Marchio, S.1
Primo, L.2
Pagano, M.3
Palestro, G.4
Albini, A.5
Veikkola, T.6
Cascone, I.7
Alitalo, K.8
Bussolino, F.9
-
27
-
-
0032812095
-
Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model
-
10473101 1:STN:280:DyaK1MvgtVSrsg%3D%3D
-
J.R. Wiener K. Nakano R.P. Kruzelock, et al. 1999 Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model Clin Cancer Res 5 8 2164 10473101 1:STN:280:DyaK1MvgtVSrsg%3D%3D
-
(1999)
Clin Cancer Res
, vol.5
, Issue.8
, pp. 2164
-
-
Wiener, J.R.1
Nakano, K.2
Kruzelock, R.P.3
|